Modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers with polyglutamine repeat length in the AIB1 gene.

被引：0
|
作者：
Hughes, D
Ginolhac, S
David, G
Sinilnikova, O
Barjhoux, L
Coupier, I
Gaborieau, V
Lenoir, G
Stoppa-Lyonnet, D
机构：
[1] Int Agcy Res Canc, F-69372 Lyon, Rhone, France
[2] Inst Curie, Paris, France
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2004年 / 13卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1900S / 1900S
页数：1
相关论文
共 50 条
  • [21] Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Salmena, Leonardo
    Oden, Lovisa
    Kim, Shana
    Akbari, Mohammad
    Sun, Ping
    Narod, Steven
    Kotsopoulos, Joanne
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (05)
  • [22] Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
    Kotsopoulos, Joanne
    Huzarski, Tomasz
    Gronwald, Jacek
    Singer, Christian F.
    Moller, Pal
    Lynch, Henry T.
    Armel, Susan
    Karlan, Beth
    Foulkes, William D.
    Neuhausen, Susan L.
    Senter, Leigha
    Tung, Nadine
    Weitzel, Jeffrey N.
    Eisen, Andrea
    Metcalfe, Kelly
    Eng, Charis
    Pal, Tuya
    Evans, Gareth
    Sun, Ping
    Lubinski, Jan
    Narod, Steven A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (01):
  • [23] Risk Management for BRCA1/BRCA2 Mutation Carriers Without and With Breast Cancer
    Mainor, C. B.
    Isaacs, C.
    CURRENT BREAST CANCER REPORTS, 2020, 12 (02) : 66 - 74
  • [24] SECOND BREAST CANCER RISK IN BRCA1 AND BRCA2 MUTATION CARRIERS PATIENTS
    Palazzo, A.
    Iacovelli, R.
    Trenta, P.
    Sidoni, T.
    Ricevuto, E.
    Naso, G.
    Giannini, G.
    Gulino, A.
    Cortesi, E.
    De Marchis, L.
    ANNALS OF ONCOLOGY, 2010, 21 : 33 - 33
  • [25] Risk Management for BRCA1/BRCA2 Mutation Carriers Without and With Breast Cancer
    C. B. Mainor
    C. Isaacs
    Current Breast Cancer Reports, 2020, 12 : 66 - 74
  • [26] Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Kleeberg, UR
    STRAHLENTHERAPIE UND ONKOLOGIE, 2003, 179 (10) : 718 - 719
  • [27] Oral contraceptives and breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Jane C. Figueiredo
    Robert W. Haile
    Jonine L. Bernstein
    Current Breast Cancer Reports, 2009, 1 (3) : 139 - 147
  • [28] Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Oden, Lovisa
    Akbari, Mohammad
    Zaman, Tasnim
    Singer, Christian F.
    Sun, Ping
    Narod, Steven A.
    Salmena, Leonardo
    Kotsopoulos, Joanne
    ONCOTARGET, 2016, 7 (52) : 86687 - 86694
  • [29] Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Narod, SA
    Dubé, MP
    Klijn, J
    Lubinski, J
    Lynch, HT
    Ghadirian, P
    Provencher, D
    Heimdal, K
    Moller, P
    Robson, M
    Offit, K
    Isaacs, C
    Weber, B
    Friedman, E
    Gershoni-Baruch, R
    Rennert, G
    Pasini, B
    Wagner, T
    Daly, M
    Garber, JE
    Neuhausen, SL
    Ainsworth, P
    Olsson, H
    Evans, G
    Osborne, M
    Couch, F
    Foulkes, WD
    Warner, E
    Kim-Sing, C
    Olopade, O
    Tung, N
    Saal, HM
    Weitzel, J
    Merajver, S
    Gauthier-Villars, M
    Jernstrom, H
    Sun, P
    Brunet, JS
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (23): : 1773 - 1779
  • [30] Breast cancer risk among male BRCA1 and BRCA2 mutation carriers
    Tai, Yu Chuan
    Domchek, Susan
    Parmigiani, Giovanni
    Chen, Sining
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (23) : 1811 - 1814
12345